Literature DB >> 32016909

Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol.

Jiunn Wong1, Wing Hang Fu2, Ee Lim Amy Lim3, Chung Fai Jeremy Ng3, Hui Lin Choong4.   

Abstract

AIM: Hyperparathyroidism in chronic kidney disease-mineral and bone disorder is associated with significant morbidity and mortality. Parathyroidectomy is widely carried out as treatment despite complications such as hypocalcaemia post-surgery. Our centre has been using an ALP-based protocol to replace calcium postoperatively to prevent hypocalcaemia. We aim to describe and audit our calcium replacement protocol post-parathyroidectomy
METHODS: We, retrospectively, analyse 167 end-stage kidney disease patients who had parathyroidectomy with auto-implantation in Singapore General Hospital between January 2008 and December 2013. Their calcium replacement postoperatively was initiated upon patient arrival back in ward on the same day of surgery based on their pre-op ALP prior to occurrence of hypocalcaemia. Patient demographics, surgical and laboratory parameters were reviewed from medical records. Changes in calcium postoperatively were reported to look for incidence of calcium derangement.
RESULTS: Mean calcium levels between pre-operation day and post-operation day 7 ranged from 2.31 to 2.70 mmol/L. Decline in serum calcium was common in all patients prior to starting calcium replacement. Eighteen patients (10.9%) experienced hypocalcaemia immediately post-operation prior to commencement of IV calcium replacement. Patients with immediate post-operation hypocalcaemia had lower pre-operation calcium but higher pre-operation alkaline phosphatase (ALP) and pre-operation intact parathyroid hormone. Hypercalcaemia is common likely from aggressive IV calcium replacement using the protocol. The average length of stay for patients prior to calcium stabilization and discharge was 9 days.
CONCLUSION: Implementation of an ALP-based prophylactic calcium replacement protocol with daily serum calcium monitoring can ameliorate severe hypocalcaemia post-parathyroidectomy.

Entities:  

Keywords:  Bone metabolism; Calcium; Dialysis; Drug monitoring; Hyperparathyroidism; Parathyroidectomy

Year:  2020        PMID: 32016909     DOI: 10.1007/s11255-020-02387-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis.

Authors:  B L Goh; M G Yudisthra; A N Hisham
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

2.  Long-Term Outcomes of Total Parathyroidectomy With or Without Autoimplantation for Hyperparathyroidism in Chronic Kidney Disease: A Meta-Analysis.

Authors:  Xiaoyan Jia; Rong Wang; Chengyin Zhang; Meiyu Cui; Dongmei Xu
Journal:  Ther Apher Dial       Date:  2015-05-06       Impact factor: 1.762

3.  Calcium supplement necessary to correct hypocalcemia after total parathyroidectomy for renal osteodystrophy.

Authors:  M Nakagawa; A Emoto; N Nasu; Y Hirata; F Sato; W Li; M Imagawa; Y Nomura
Journal:  Int J Urol       Date:  2000-02       Impact factor: 3.369

4.  Efficacy of an intravenous calcium gluconate infusion in controlling serum calcium after parathyroidectomy for secondary hyperparathyroidism.

Authors:  Seng Cheong Loke; Ravindran Kanesvaran; Rosnawati Yahya; Liza Fisal; Teck Wee Wong; Yik Yee Loong
Journal:  Ann Acad Med Singapore       Date:  2009-12       Impact factor: 2.473

5.  Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with No access to renal transplantation in Singapore.

Authors:  Parameswaran Rajeev; Kai Yin Lee; Xin Jie Tang; Tiong Thye Goo; Wee Boon Tan; Kee Yuan Ngiam
Journal:  Int J Surg       Date:  2015-11-21       Impact factor: 6.071

6.  Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Margaret J Blayney; Justin M Albert; Brenda W Gillespie; Peter G Kerr; Jürgen Bommer; Eric W Young; Tadao Akizawa; Takashi Akiba; Ronald L Pisoni; Bruce M Robinson; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2008-06-02       Impact factor: 8.860

Review 7.  Management of calcium refilling post-parathyroidectomy in end-stage renal disease.

Authors:  Mario Cozzolino; Maurizio Gallieni; Carlo Corsi; Amelia Bastagli; Diego Brancaccio
Journal:  J Nephrol       Date:  2004 Jan-Feb       Impact factor: 3.902

8.  Fracture risk after parathyroidectomy among chronic hemodialysis patients.

Authors:  Kyle D Rudser; Ian H de Boer; Annemarie Dooley; Bessie Young; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2007-07-18       Impact factor: 10.121

9.  Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism.

Authors:  Pingjiang Ge; Shuangxin Liu; Xiaoli Sheng; Sijia Li; Mimi Xu; Jie Jiang; Shaohua Chen
Journal:  Head Neck       Date:  2017-09-30       Impact factor: 3.147

10.  Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients.

Authors:  Marius C Florescu; Km Monirul Islam; Troy J Plumb; Sara Smith-Shull; Jennifer Nieman; Prasanti Mandalapu
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-05-14
View more
  2 in total

1.  Risk Factors for Severe Hypocalcemia in Patients with Secondary Hyperparathyroidism after Total Parathyroidectomy.

Authors:  Ping Wen; Lingling Xu; Shasha Zhao; Wei Gan; Dawei Hou; Liang Zhang; Jinlong Cao; Mingxia Xiong; Lei Jiang; Junwei Yang
Journal:  Int J Endocrinol       Date:  2021-04-02       Impact factor: 3.257

2.  Factors influencing the development of bone starvation syndrome after total parathyroidectomy in patients with renal hyperparathyroidism.

Authors:  Xuyang Peng; Xiaofang Xia; Zhouting Li; Feng Cheng; Xi Zhu
Journal:  Front Surg       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.